Shandong Weigao Group Medical Polymer Zukünftiges Wachstum

Future Kriterienprüfungen 1/6

Shandong Weigao Group Medical Polymer wird ein jährliches Gewinn- und Umsatzwachstum von 10.1% bzw. 7.1% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 10% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 9.2% betragen.

Wichtige Informationen

10.1%

Wachstumsrate der Gewinne

10.0%

EPS-Wachstumsrate

Medical Equipment Gewinnwachstum	40.3%
Wachstumsrate der Einnahmen	7.1%
Zukünftige Eigenkapitalrendite	9.2%
Analystenabdeckung	Good
Zuletzt aktualisiert	21 Nov 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

Gewinn- und Umsatzwachstumsprognosen

SZSC:1066 - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (CNY Millions)
Datum	Umsatz	Gewinne	Freier Cashflow	Bargeld aus operativen Tätigkeiten	Durchschn. Anz. Analysten
12/31/2026	15,585	2,501	2,201	3,576	6
12/31/2025	14,731	2,319	1,962	3,013	7
12/31/2024	13,819	2,135	2,086	2,716	7
6/30/2024	12,967	1,912	2,018	2,704	N/A
3/31/2024	13,098	1,957	2,066	2,751	N/A
12/31/2023	13,229	2,002	2,113	2,799	N/A
9/30/2023	13,398	2,221	1,639	2,539	N/A
6/30/2023	13,566	2,440	1,166	2,280	N/A
3/31/2023	13,657	2,602	1,173	2,287	N/A
12/31/2022	13,747	2,764	1,181	2,295	N/A
9/30/2022	13,903	2,676	1,433	2,573	N/A
6/30/2022	14,058	2,589	1,685	2,852	N/A
3/31/2022	13,633	2,432	1,803	2,969	N/A
12/31/2021	13,209	2,276	1,920	3,087	N/A
9/30/2021	12,923	2,288	2,021	3,088	N/A
6/30/2021	12,636	2,300	2,121	3,089	N/A
3/31/2021	12,129	2,194	1,971	2,938	N/A
12/31/2020	11,622	2,087	1,821	2,788	N/A
9/30/2020	11,139	1,998	1,557	2,533	N/A
6/30/2020	10,656	1,909	1,292	2,277	N/A
3/31/2020	10,520	1,879	1,315	2,300	N/A
12/31/2019	10,384	1,850	1,337	2,322	N/A
9/30/2019	9,993	1,805	1,456	2,347	N/A
6/30/2019	9,602	1,760	1,575	2,371	N/A
3/31/2019	9,205	1,616	1,500	2,295	N/A
12/31/2018	8,809	1,473	1,424	2,219	N/A
6/30/2018	7,465	1,255	383	1,812	N/A
3/31/2018	6,879	1,255	N/A	1,539	N/A
12/31/2017	6,293	1,255	N/A	1,266	N/A
6/30/2017	5,402	1,297	N/A	1,233	N/A
3/31/2017	5,511	1,165	N/A	1,143	N/A
12/31/2016	5,620	1,033	N/A	1,053	N/A
9/30/2016	6,484	1,010	N/A	1,042	N/A
6/30/2016	6,237	914	N/A	1,030	N/A
3/31/2016	6,078	1,013	N/A	1,041	N/A
12/31/2015	5,919	1,113	N/A	1,053	N/A
9/30/2015	5,878	1,237	N/A	N/A	N/A
6/30/2015	5,610	1,196	N/A	622	N/A
3/31/2015	5,548	1,161	N/A	N/A	N/A
12/31/2014	5,278	1,085	N/A	711	N/A
9/30/2014	5,011	307	N/A	N/A	N/A
6/30/2014	4,996	431	N/A	794	N/A
3/31/2014	4,769	376	N/A	N/A	N/A
12/31/2013	4,613	388	N/A	720	N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: 1066Das prognostizierte Gewinnwachstum (10.1% pro Jahr) liegt über der Sparquote (2.3%).

Ertrag vs. Markt: 1066Die Erträge des Unternehmens (10.1% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt Hong Kong (11.5% pro Jahr).

Hohe Wachstumserträge: 1066Die Erträge des Unternehmens werden voraussichtlich steigen, jedoch nicht deutlich.

Einnahmen vs. Markt: 1066Die Einnahmen des Unternehmens (7.1% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt Hong Kong (7.8% pro Jahr).

Hohe Wachstumseinnahmen: 1066Die Einnahmen des Unternehmens (7.1% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: 1066Die Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (9.2%).

Shandong Weigao Group Medical Polymer Zukünftiges Wachstum

Future Kriterienprüfungen 1/6

Wichtige Informationen

Jüngste Aktualisierungen zum künftigen Wachstum

Shandong Weigao Group Medical Polymer Company Limited Provides Earnings Guidance for the Year Ended 31 December 2023

Recent updates

Shandong Weigao Group Medical Polymer Company Limited Approves the Distribution of Interim Dividend for the Six Months Ended 30 June 2024, Payable on 22 November 2024

Investor sentiment deteriorates as stock falls 17%

Upcoming dividend of CN¥0.092 per share

Investor sentiment improves as stock rises 16%

First half dividend of CN¥0.092 announced

First half 2024 earnings released: EPS: CN¥0.25 (vs CN¥0.27 in 1H 2023)

Shandong Weigao Group Medical Polymer Company Limited Proposes an Interim Dividend for the Six Months Ended 30 June 2024, Payable on Before 22 November 2024

Shandong Weigao Group Medical Polymer Company Limited to Report First Half, 2024 Results on Aug 28, 2024

Shandong Weigao Group Medical Polymer Company Limited Approves Board Appointments

Upcoming dividend of CN¥0.094 per share

Full year 2023 earnings released: EPS: CN¥0.44 (vs CN¥0.61 in FY 2022)

Final dividend of CN¥0.094 announced

Shandong Weigao Group Medical Polymer Company Limited, Annual General Meeting, May 28, 2024

Full year 2023 earnings released: EPS: CN¥0.44 (vs CN¥0.60 in FY 2022)

Shandong Weigao Group Medical Polymer Company Limited Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 12 July 2024

Shandong Weigao Group Medical Polymer Company Limited to Report Fiscal Year 2023 Results on Mar 26, 2024

Shandong Weigao Group Medical Polymer Company Limited Provides Earnings Guidance for the Year Ended 31 December 2023

Investor sentiment deteriorates as stock falls 18%

Shandong Weigao Group Medical Polymer Company Limited Announces the Resignation of Ni Has Tendered as Executive Director, Effective from 31 December 2023

Shandong Weigao Group Medical Polymer Company Limited Approves Distribution of Interim Dividend for the Six Months Ended 30 June 2023

Upcoming dividend of CN¥0.073 per share at 2.4% yield

First half 2023 earnings released: EPS: CN¥0.27 (vs CN¥0.34 in 1H 2022)

Shandong Weigao Group Medical Polymer Company Limited Proposes Interim Dividend for the Six Months Ended 30 June 2023, Payable on 24 November 2023

Shandong Weigao Group Medical Polymer Company Limited to Report First Half, 2023 Results on Aug 29, 2023

Now 21% undervalued after recent price drop

Shandong Weigao Group Medical Polymer Company Limited Approves Final Dividend for the Year Ended 31 December 2022, Payable on or Before 14 July 2023

Upcoming dividend of CN¥0.079 per share at 1.5% yield

Full year 2022 earnings released: EPS: CN¥0.60 (vs CN¥0.51 in FY 2021)

Shandong Weigao Group Medical Polymer Company Limited Appoints Li Qiang as an Independent Non-Executive Director

Key Executive recently sold HK$5.8m worth of stock

Now 22% undervalued

Less than half of directors are independent

Shandong Weigao Group Medical Polymer Company Limited Announces Resignation of Wang Jinxia as an Independent Non-Executive Director of the Company, A Member of Audit Committee, A Member of Remuneration Committee, A Member of Nomination Committee and A Member of Corporate Governance Committee

Now 20% undervalued

Shandong Weigao Group Medical Polymer Company Limited Approves Interim Dividend for the Six Months Ended June 30, 2022, Payable on November 11, 2022

Upcoming dividend of CN¥0.086 per share

Shandong Weigao Group Medical Polymer Company Limited (SEHK:1066) agreed to acquire Weihai Weigao Medical Materials Company Limited from Weigao Holding Company Limited for approximately RMB288.0 million.

First half 2022 earnings released: EPS: CN¥0.32 (vs CN¥0.27 in 1H 2021)

Shandong Weigao Group Medical Polymer Company Limited Announces Executive Changes

Shandong Weigao Group Medical Polymer Company Limited to Report First Half, 2022 Results on Aug 22, 2022

Investor sentiment improved over the past week

Shandong Weigao Group Medical Polymer Company Limited Approves Executive Appointments

Upcoming dividend of CN¥0.065 per share

Now 22% undervalued after recent price drop

Full year 2021 earnings released: EPS: CN¥0.50 (vs CN¥0.47 in FY 2020)

Less than half of directors are independent

Shandong Weigao Group Medical Polymer Company Limited Announces Executive Resignations

Shandong Weigao Group Medical Polymer Company Limited, Annual General Meeting, Jun 06, 2022

Full year 2021 earnings released: EPS: CN¥0.50 (vs CN¥0.45 in FY 2020)

Shandong Weigao Group Medical Polymer Company Limited Recommends Final Dividend for the Year Ended December 31, 2021

Investor sentiment improved over the past week

Shandong Weigao Group Medical Polymer Company Limited to Report Q4, 2021 Results on Mar 29, 2022

Upcoming dividend of CN¥0.077 per share

First half 2021 earnings released: EPS CN¥0.27 (vs CN¥0.22 in 1H 2020)

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Shandong Weigao Group Medical Polymer Company Limited Approves Final Dividend for the Year Ended December 31, 2020 At the Annual General Meeting Held on May 24, 2021

Upcoming dividend of CN¥0.068 per share

Full year 2020 earnings released: EPS CN¥0.45 (vs CN¥0.41 in FY 2019)

Chairman & Compliance Officer Hua Wei Zhang has left the company

Executive Vice Chairman Yi Wang has left the company

Shandong Weigao Group Medical Polymer Company Limited Approves the Appointment of Tang Zheng Peng as a Non-Executive Director of the Company

New 90-day low: HK$13.28

Shandong Weigao Group Medical Polymer Company Limited to Report Fiscal Year 2020 Results on Mar 30, 2021

Chairman & Compliance Officer recently sold HK$14m worth of stock

New 90-day high: HK$17.06

Shandong Weigao Group Medical Polymer Company Limited Announces Director Changes

New 90-day low: HK$14.22

New 90-day low: HK$14.82

New 90-day low: HK$15.04

First half earnings released

New 90-day low: HK$15.96

Earnings released

New 90-day high - HK$21.90